CT-P13: a review on a biosimilar to infliximab in the treatment of inflammatory bowel disease, Ahmad Albshesh, Shomron Ben-Horin, - Expert Opinion on Biological Therapy   " Introduction : CT-P13 was developed as an infliximab biosimilar in 2013. The primary structure of CT-P13 is identical to that of original inflixima..." | Read Full Text >

Check out what else is new for you this week...

Ramucirumab For the Treatment of Gastric or Gastro-Esophageal Junction Cancer Uqba Khan, Manish A. Shah, - Expert Opinion on Biological Therapy " Introduction : Gastric cancer remains one of the most lethal malignancy, accounting for an estimated 783,000 deaths worldwide in 2018. Although there are severa" | Read now >         Pembrolizumab for the treatment of diffuse large B-cell lymphoma Semira Sheikh, J Kuruvilla, - Expert Opinion on Biological Therapy " Introduction : Pembrolizumab is a novel monoclonal antibody that targets the interaction between programmed cell death protein 1 (PD-1) and its ligand (PD-L1)." | Read now >         Patients don’t come with multiple choice options: Essay-based assessment in UME Jeffrey Bird, Doreen Olvet, Joanne Willey - Medical Education Online " Curricular revision efforts have resulted in learner-centered programs that value content integration and active learning. Yet, less attention has been placed on assessment" | Read now >         The applications of Big Data in molecular diagnostics Evelyn Wong, Ka Lam, Ka Ho - Expert Review of Molecular Diagnostics " Introduction : Big Data technologies instilled an informational perspective to our understanding of the world. However, fundamental issues such as the managemen" | Read now >